Download PDF
1 / Pages

Other users also viewed these articles

Looking into a new era for the approach of metabolic (dysfunction) associated fatty liver disease Alejandro Valencia-Rodríguez; Alfonso Vera-Barajas; Norberto C. Chávez-Tapia; Misael Uribe; Nahum Méndez-Sánchez;
Ann Hepatol. 2020;19:227-9
Relationship between sarcopenia and metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis Adnan Malik; Sadia Javaid; Muhammad Imran Malik; Shahbaz Qureshi;
10.1016/j.aohep.2024.101544
Prevalence of non-alcoholic fatty liver disease and liver fibrosis in a general population cohort from Argentina Federico Guillermo Villamil; Manuel Barbero; Nancy Elena Massenzio; Sandra Mónica Giani; Shigeru Kozima; Fernando Mario Cairo; Rodrigo Agustín Belloni; Javier Mariani; Mercedes Rodriguez Gazari; Paola Evangelina Coisson; Sonia Carolina Gallardo; Paula Andrea Cocco; Claudia Mabel Riboldi; Patricia Eugenia Gallardo;
Ann Hepatol. 2023;28: